ADLENS IPR LIMITED

Active Eynsham

Non-trading company

0 employees website.com
Non-trading company
A

ADLENS IPR LIMITED

Non-trading company

Founded 15 Jan 2008 Active Eynsham, United Kingdom 0 employees website.com
Non-trading company

Previous Company Names

ADLENS GLOBAL RETAIL LIMITED 13 Feb 2014 — 3 Mar 2014
ADLENS IPR LIMITED 15 Jan 2008 — 13 Feb 2014
Accounts Submitted 6 May 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 25 Feb 2026 Next due 29 Jan 2027 8 months remaining
Net assets £1 £0 2024 year on year
Total assets £1 £0 2024 year on year
Total Liabilities £0
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Chilbrook House 1 Oasis Park Stanton Harcourt Road Eynsham Oxfordshire OX29 4TP United Kingdom

Full company profile for ADLENS IPR LIMITED (06472945), an active company based in Eynsham, United Kingdom. Incorporated 15 Jan 2008. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type dormant
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Loesel, Frieder Hans, DrDirectorGermanGermany5810 Jan 2026Active
Ng, SandyDirectorSingaporeanSingapore4710 Jan 2026Active
Tomasic, Paul AnthonyDirectorBritishEngland521 May 2026Active

Shareholders

Shareholders (1)

Adlens Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Adlens Group Limited

United Kingdom

Active
Notified 3 May 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ADLENS GROUP LIMITED united kingdom
ADLENS IPR LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 May 2026AccountsAnnual accounts made up to 31 Dec 2025
5 May 2026OfficersAppointment of Mr Paul Anthony Tomasic as director on 1 May 2026
25 Feb 2026Confirmation StatementConfirmation statement made on 15 Jan 2026 with no updates
19 Jan 2026OfficersAppointment of Ms Sandy Ng as director on 10 Jan 2026
19 Jan 2026OfficersAppointment of Dr Frieder Hans Loesel as director on 10 Jan 2026
6 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

5 May 2026 Officers

Appointment of Mr Paul Anthony Tomasic as director on 1 May 2026

25 Feb 2026 Confirmation Statement

Confirmation statement made on 15 Jan 2026 with no updates

19 Jan 2026 Officers

Appointment of Ms Sandy Ng as director on 10 Jan 2026

19 Jan 2026 Officers

Appointment of Dr Frieder Hans Loesel as director on 10 Jan 2026

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

3 weeks ago on 6 May 2026

Appointment of Mr Paul Anthony Tomasic as director on 1 May 2026

3 weeks ago on 5 May 2026

Confirmation statement made on 15 Jan 2026 with no updates

3 months ago on 25 Feb 2026

Appointment of Ms Sandy Ng as director on 10 Jan 2026

4 months ago on 19 Jan 2026

Appointment of Dr Frieder Hans Loesel as director on 10 Jan 2026

4 months ago on 19 Jan 2026